The use of biologics and anti-tumor necrosis factor drugs (anti-TNF) is associated with an increased risk of infections including tuberculosis (TB) [2–5], and possibly viral hepatitis B (HBV) and viral hepatitis C (HCV) [6–8]. Here, TNF is linked to viral hepatitis.